During development, Drosophila larvae undergo a dramatic increase in body mass wherein nutritional and developmental cues are transduced into growth through the activity of complex signaling pathways. Class I phosphoinositide 3-kinases have an established role in this process. In this study we identify Drosophila phosphatidylinositol 5-phosphate 4-kinase (dPIP4K) as a phosphoinositide kinase that regulates growth during larval development. Loss-of-function mutants in dPIP4K show reduced body weight and prolonged larval development, whereas overexpression of dPIP4K results both in an increase in body weight and shortening of larval development. The growth defect associated with dPIP4K loss of function is accompanied by a reduction in the average cell size of larval endoreplicative tissues. Our findings reveal that these phenotypes are underpinned by changes in the signaling input into the target of rapamycin (TOR) signaling complex and changes in the activity of its direct downstream target p70 S6 kinase. Together, these results define dPIP4K activity as a regulator of cell growth and TOR signaling during larval development.
During development, Drosophila larvae undergo a dramatic increase in body mass wherein nutritional and developmental cues are transduced into growth through the activity of complex signaling pathways. Class I phosphoinositide 3-kinases have an established role in this process. In this study we identify Drosophila phosphatidylinositol 5-phosphate 4-kinase (dPIP4K) as a phosphoinositide kinase that regulates growth during larval development. Loss-of-function mutants in dPIP4K show reduced body weight and prolonged larval development, whereas overexpression of dPIP4K results both in an increase in body weight and shortening of larval development. The growth defect associated with dPIP4K loss of function is accompanied by a reduction in the average cell size of larval endoreplicative tissues. Our findings reveal that these phenotypes are underpinned by changes in the signaling input into the target of rapamycin (TOR) signaling complex and changes in the activity of its direct downstream target p70 S6 kinase. Together, these results define dPIP4K activity as a regulator of cell growth and TOR signaling during larval development. D uring postembryonic development, Drosophila larvae undergo a period of rapid growth that lasts for approximately 96 h during which larvae undergo rapid growth with body weight increasing by two log units. This dramatic increase in larval body weight is almost entirely underpinned by increases in the cell size of larval-specific endoreplicative tissues (1) . The extent of growth during larval life is critical as adult body size in insects is predetermined during larval development. Consequently, larval growth is a carefully regulated process (2) and insect larvae must attain a so-called minimum viable weight to trigger developmental cues that signal termination of larval growth and the onset of pupal metamorphosis.
Several factors contribute to normal larval growth. At an organismal level, these include the availability of adequate nutrition, the ability to feed (reviewed in ref. 3) , as well as endocrine signals that regulate nutrient utilization and coordinate growth with metamorphosis. At the cellular level, key contributors to larval growth are the activity of signaling cascades that transduce nutrient availability and regulate their utilization to generate cellular and body mass. These include the activity of Drosophila insulin-like peptides (DILPs) acting via the insulin receptor and that of the target of rapamycin (TOR) pathway. Phosphoinositide kinases have key roles within both the insulin (4) and TOR signaling pathways (5) . The generation of phosphatidylinositol 3,4,5 trisphosphate (PIP 3 ) by class I phosphoinositide 3-kinases (PI3Ks) is an essential early step following insulin receptor activation. Likewise the generation of phosphatidylinositol 3-phosphate (PI3P) via class III PI3K/vacuolar protein sorting 34 (Vps34) is reported to be a key signaling input into TOR activity in mammalian cells (6) .
Phosphoinositides are phosphorylated derivatives of phosphatidylinositol (PI), several of which are known to regulate fundamental cellular processes in eukaryotes. These phosphorylations are catalyzed by an evolutionarily conserved family of lipid kinases that are stereospecific with respect to the positions on the inositol headgroup that they can phosphorylate and also show specificity for their preferred substrate. One such enzyme is phosphatidylinositol 5-phosphate 4-kinase (PIP4K) previously known as type II phosphatidylinositolphosphate (PIP) kinase (7) . In vitro, PIP4K enzymes can phosphorylate both PI5P and PI3P to produce PI(4,5)P 2 and PI(3,4)P 2 , respectively (8, 9) . Genes encoding PIP4K activity are present in sequenced metazoan genomes but not in those of unicellular eukaryotes such as yeast. PIP4K enzymes are biochemically distinct from the closely related family of phosphatidylinositol 4-phosphate 5 kinase (PIP5K). PIP5Ks use PI4P as a substrate to generate PI(4,5)P 2 and are presumed to underlie the synthesis of the major pools of cellular PI(4,5)P 2 . PIP5Ks have been known to regulate many cellular processes including cell migration, focal adhesion assembly/disassembly, cell division, polarity, and vesicular trafficking (10) . Functional analysis in vivo has shown that the distinct in vitro substrate specificity of PIP5K and PIP4K is also relevant to in vivo function (11) (12) (13) , implying that PIP4Ks may modulate a set of cellular processes distinct from those controlled by PIP5Ks. However, in contrast to PIP5Ks little is known about the physiological functions of PIP4Ks.
Mammalian genomes contain three genes (α, β, and γ) that encode PIP4K activity. PIP4Kα encodes a protein localized primarily in the cytosol (reviewed in ref. 14) ; no in vivo function has been ascribed to this gene. PIP4Kβ encodes a protein that is nuclear localized (15) and its activity has been implicated in the regulation of cellular responses in the nucleus during UV irradiation (16) . In addition, altered PIP4Kβ activity has been reported to regulate the sensitivity of mammalian cells to insulin signaling. Expression of PIP4Kβ in CHO cells results in down-regulation of PIP 3 production and AKT (protein kinase B) phosphorylation in response to insulin stimulation (17) , whereas skeletal muscle cells from PIP4Kβ −/− mice show enhanced sensitivity to insulin stimulation (18) . PIP4Kγ encodes a protein that appears to localize to endomembrane compartments whose identity is unclear (19) . Whereas these studies suggest important cellular functions for PIP4K enzymes, the physiological significance and the mechanism by which this unique class of lipid kinase exerts its effects remain unclear. In this study, we have analyzed the single PIP4K gene encoded in the Drosophila genome. Our studies reveal a functional role for Drosophila PIP4K (dPIP4K) activity in regulating cell growth via the TOR pathway during Drosophila larval development.
Results
Single Gene Encoding PIP4K in Drosophila. We used mouse PIP4KIIα sequence as a query and performed a BLAST analysis of the completed genome sequence of Drosophila. This revealed a single hit corresponding to the gene named CG17471. CG17471 is located on chromosome 4, cytogenetic position 102F8. Computationally, two splice variants of CG17471 are predicted that differ in a noncoding exon but encode an identical 404-amino-acid protein. Analysis of the encoded protein sequence with INTER-PRO revealed that amino acids 31-403 encode a "PIP kinase catalytic domain" [Interpro (IPR) 002498]. Inspection of the region corresponding to the "activation loop" (20) whose sequence is reported to correlate with PIP5K versus PIP4K activity (13) suggests that CG17471 encodes a PIP4K activity (Fig. 1A) . Finally inspection of the single amino acid at position 381 within the activation loop of human PIP4K (Fig. 1A, arrow) , which is reported to define the stereospecific activity of a PIPK enzyme (12) , revealed that the equivalent residue in CG17471 is an alanine rather than a glutamate. Together these bioinformatic analyses suggest that CG17471 encodes the single PIP4K (hereafter called dPIP4K) in the Drosophila genome. Analysis of genome sequences of the 11 other Drosophila species as well as that of other sequenced insect genomes reveals the existence of a single PIP4K-like gene.
We identified a full-length cDNA for the dPIP4K locus (LD10864). This cDNA includes a 404-amino-acid ORF that encodes a protein identical to that predicted by computational analysis of the dPIP4K locus (Fig. 1B) . We expressed this cDNA and tested the activity of purified recombinant protein in an in vitro lipid kinase assay. When presented with PI5P as a substrate, this protein showed PIP4K activity (Fig. 1C) , being able to convert PI5P into PI(4,5)P 2 but showed no activity toward PI or PI3P substrates (Fig. S1 ). dPIP4K also showed minimal activity toward PI4P as a substrate (Fig. S1 ) and this substrate specificity recapitulates that of human PIP4Kα under the same conditions (8, 21) . Taken together these data show that dPIP4K encodes a functional PIP4K activity.
dPIP4K Regulates PI5P Levels in Vivo. A loss-of-function mutant in this gene was generated using ends-out homologous recombination. The resulting mutant allele (dPIP4K
29
) disrupts the kinase domain and should produce no functional protein ( Fig. 2A) . Using an antibody generated against dPIP4K, we found that dPIP4K 29 is a protein null allele (Fig. 2B) .
To understand the biochemical consequences of dPIP4K loss of function we measured the levels of PI4P, PI5P, and PI(4,5)P 2 in lipid extracts from flies. This revealed that PI5P levels in dPIP4K 29 were twice that measured in wild-type controls (Fig. 2D) ; by contrast, the levels of PI4P (Fig. 2C) and PI(4,5)P 2 levels were not reduced (Fig. 2F) . We reconstituted dPIP4K 29 with either a wildtype dPIP4K transgene or the point mutant allele [amino acid 271 (D271K) was mutated from aspartic acid to lysine, Fig. 1C ] that is kinase dead. Transgenes were expressed using the ubiquitous actin-GAL4 driver that drives expression throughout the fly. Biochemical analysis revealed that when dPIP4K 29 is reconstituted with a wild-type transgene, the elevated PI5P levels were reversed toward wild-type levels (Fig. 2E) ; this was not seen with a kinase dead transgene (Fig. 2E) . These results strongly suggest that the kinase activity of dPIP4K is required to maintain PI5P levels in vivo.
dPIP4K Activity Regulates Growth and the Rate of Larval Development.
Although dPIP4K
29 embryos develop into homozygous adults with apparently normal external morphology, a detailed analysis of larval growth revealed significant developmental defects. Whereas both wild-type and dPIP4K 29 animals showed equivalent body weight soon after hatching, dPIP4K 29 larvae weighed less than their wild-type counterparts at multiple time points during development (Fig. 3A) . The maximum difference in body weight was at 60 h posthatching (at 22°C) when dPIP4K 29 larvae weighed approximately 54% of controls; toward the end of larval development this difference is relatively reduced (dPIP4K 29 larvae weigh approximately 85% of wild-type controls) but with a delay of approximately 12 h (Fig. 3A) . The reduction in body weight was substantially rescued by reconstitution of dPIP4K 29 using a wild-type dPIP4K transgene ( Fig. 3 B and C) . Consistent with the idea that adult body size in insects is predetermined during larval development we observed that newly eclosed adult dPIP4K 29 flies weighed less than the wild-type controls (Fig. 3H ). Moreover, we observed that ubiquitous overexpression of dPIP4K in larval cells increased body weight compared with controls ( Fig.  3 D and E). Collectively these data strongly suggest that dPIP4K function is required to regulate growth during larval development. Skittles, a Drosophila PIP5K; CG17471, a Drosophila PIP4K. The region corresponding to the activation loop is marked by a solid black line. In the region of the activation loop, residues that are identical in both PIP4K and PIP5K are marked in dark blue with conserved substitutions in light blue. Residues conserved among PIP5K proteins are marked in green with conserved substitutions in light green. Residues conserved among PIP4K proteins are marked in red. Arrow indicates the single residue that has been shown to determine PIP5K vs. PIP4K activity. (B) Protein sequence encoded by the ORF of the cDNA clone LD10864 that encodes dPIP4K. The sequence of the activation loop is marked in red. The single residue with the activation loop that has been shown to determine PIP4K vs. PIP5K for the human protein is shown in green. The residue shown to be phosphorylated by protein kinase D (PKD) in hsPIP4Kb is shown in blue. (C) Lipid kinase activity of wild-type and mutant dPIP4K. Recombinant phosphatidylinositol (PtdIns) 5-phosphate 4-kinase protein expressed and purified from constructs encoding the human PIP4Kα isoform (hPIP4K), wild-type D. melanogaster PIP4K (dPIP4K), and a kinase-dead (D271K) mutant of the Drosophila enzyme (dPIP4K K/D ) were assayed for lipid kinase activity as described in SI Materials and Methods. Radiolabeled PI(4,5)P 2 product (arrowhead) was identified by silica TLC and autoradiography. Samples from different sections of the same TLC plate are aligned for convenience.
Following embryogenesis, the time taken to complete larval development is inversely related to gain in body weight (2) . Consistent with this idea, we found that the time spent in larval development before pupariation was longer in dPIP4K 29 compared with controls. Whereas approximately 80% of wild-type larvae had pupariated by 5 d posthatching, only 20% of dPIP4K 29 animals had done so (Fig. 3F) . dPIP4K 29 animals continued larval development several days after wild-type controls had all pupariated. Conversely, larval development was accelerated by overexpressing dPIP4K (Fig. 3I) , whereas larvae overexpressing a kinase dead transgene pupariated with a delay (Fig. 3I) . We also reduced dPIP4K transcripts in wild-type larvae by expressing a transgenic RNAi construct ubiquitously during larval development; this resulted in a reduction in body weight as well as delayed pupariation reminiscent of that seen in dPIP4K 29 ( Fig. S2 ). Together these findings imply that the level of dPIP4K activity regulates body weight and developmental rate during larval development.
dPIP4K Regulates Cell Size and phosphorylated p70 S6 kinase (pS6K) in Larval Cells. Because most growth in Drosophila larvae is through an increase in the cell size of endoreplicative tissues, we asked if cell size was altered in dPIP4K 29 . Analysis of salivary glands revealed that the average size of cells was lower in dPIP4K 29 compared with wild type (Fig. 4 A and B) . Notably, the reduced cell size in dPIP4K 29 was rescued by reconstitution with a dPIP4K transgene (Fig. 4 A and B) and dPIP4K overexpression in larval cells resulted in an increase of salivary gland cell size (Fig. 4I) . These results highlight the requirement of dPIP4K function in regulating cell size in larval endoreplictaive tissues. In both Drosophila and mammals, the protein kinase AGC family member, p70 S6 kinase (S6K) is a positive regulator of cell size (22) and its activity is regulated by phosphorylation. We found that in larval extracts from dPIP4K 29 , the levels of phosphorylated S6K (pS6K) were lower than in controls (Fig. 4C) . Conversely, overexpression of wild-type dPIP4K ubiquitously in larvae (Fig. 4D) but not a kinase dead version (Fig. 4E ) resulted in increased pS6K levels. To test the role of reduced pS6K levels in the growth defects of dPIP4K 29 , we overexpressed Drosophila S6K (dS6K) in larval cells. The ubiquitous overexpression of dS6K in wild-type larvae results in an increase in larval body weight to about 1.25 times that of controls (Fig. 4 F and G) . In 29 animals a similar overexpression of dS6K resulted in an approximately 2.25 times increase in bodyweight (Fig. 4G ) such that the body weight was restored almost back to wild-type levels (Fig. 4F) . Further, analysis of salivary gland cell size showed that in these animals salivary gland cell size was also reverted back toward wild type (Fig. 4H ). These observations imply that reduced S6K activity underpins the reduced cell size and body weight observed in dPIP4K 29 larvae.
Reduced TOR Activity in dPIP4K 29 Larvae. The phosphorylation of S6K is principally mediated by the Ser/Thr kinase TOR, specifically the TOR complex 1 (TORC1) (23) . To test the levels of functional TORC1, we grew larvae on food containing 2 μM rapamycin, a small molecule that universally inhibits the TORC1 complex (24) (but which may also inhibit TOR complex 2 (TORC2) in some settings) and measured the rate of larval development. As previously reported (25), we found that wildtype larvae grown on food containing rapamycin show a delay in larval development. Whereas approximately 80% of wild-type animals growing on control food had pupariated by day 5 posthatching, none of the animals grown on 2 μM rapamycin had pupariated by this time point (Fig. 5A) . The response of dPIP4K 29 larvae to rapamycin treatment was dramatically different. Whereas 50% of dPIP4K 29 larvae grown on control medium had pupariated by day 7, there were no pupae seen among dPIP4K 29 larvae grown on 2 μM rapamycin. Even at 14 d posthatching <50% of dPIP4K 29 animals grown on rapamycin had pupated, whereas >80% of animals grown on control food had done so (Fig. 5A) . These results highlight the enhanced sensitivity of dPIP4K 29 to rapamycin and suggest that TORC1 activity in reduced in dPIP4K 29 larvae compared with wild type. Conversely, when grown on rapamycincontaining food, animals overexpressing dPIP4K were less sensitive to rapamycin and showed accelerated development compared with nonoverexpressing controls (Fig. 5B) .
We also studied the phosphorylation of protein kinase B (AKT) at S505 (p-AKT S505 , equivalent to S473 in mammalian AKT) by the rapamycin-insensitive TORC2 complex (26) . AKT is a key regulator of cellular growth in response to nutrient and growth factor signaling. These studies revealed that the level of p-AKT S505 was substantially reduced in protein extracts from wandering third instar larvae of dPIP4K 29 compared with controls ( Fig. 5C ), implying that the activity of TORC2 is also down-regulated in cells lacking dPIP4K activity. Conversely, overexpression of dPIP4K during larval development results in an increase in the levels of p-AKT S505 (Fig. 5D) , whereas overexpression of a kinase dead 29 larvae grown posthatching on fly food containing 2 μM rapamycin or an equal volume of vehicle control (n = 80). (B) Rate of pupariation of larvae overexpressing dPIP4K and nonexpressing controls grown on food containing 2 μM rapamycin. In both cases, y-axis shows the cumulative percentage of larvae (average of three independent experiments) pupariated at a given time posthatching. X-axis shows the time in hours posthatching. The dotted line indicates the level of 50% pupariation. The hastening in 50% pupariation of larvae overexpressing dPIP4K was statistically significant compared with nonexpressing controls (P value <0.05 vs. da-GAL4 and P value <0.01 vs. UAS-dPIP4K). Western blots from protein extracts of third instar larvae that have just initiated wandering behavior. (C) Reduced phosphorylation of AKT using an antibody that detects phosphorylation at Ser505 [p-AKT(Ser (K/D) version of dPIP4K resulted in reduced p-AKT S505 levels (Fig. 5E) .
Overexpression of Ras Homolog Enriched in Brain (Rheb) Rescues the Growth Defect of dPIP4K 29 . A key signaling input that regulates TOR activity is the small GTPase Ras homolog enriched in brain (Rheb) (27) . To test if signaling inputs that regulate TOR activity were altered, we studied the effect of overexpressing Drosophila Rheb (dRheb). Overexpression of dRheb in wild-type larvae results in a small but consistent increase in body weight (Fig. 5F ). When dRheb was overexpressed in dPIP4K 29 larvae, there was a dramatic increase in body weight such that these larvae now weighed almost as much as wild type (Fig. 5F ). The proportional increase in body weight was nearly 2.25 times compared with dPIP4K 29 larvae not overexpressing dRheb (Fig. 5G) . Analysis of salivary gland cell size in dPIP4K 29 larvae overexpressing dRheb showed that the reduced cell size in dPIP4K 29 was reverted back toward wild type (Fig. 5H ). These findings strongly suggest that the underlying reason for the reduced growth and TORC activity in dPIP4K 29 is a lack of signaling input to stimulate TOR activity via Rheb.
Discussion
During Drosophila larval development, nutritional and environmental cues are transduced into cellular growth and increased body size. In this setting generation of the phosphoinositides, PIP 3 and PI3P, play an important role and the kinases that synthesize these lipids namely class I and class III PI3K, respectively, are established regulators of cellular growth. In this study, we report the identification of dPIP4K as a lipid kinase that regulates growth during Drosophila development. We find that a null mutant in dPIP4K shows impaired growth during larval development. This phenotype is reminiscent of that seen in a mouse knockout of PIP4Kβ (18); these mice are reported to be smaller than wild-type controls and together with our findings suggest an evolutionarily conserved role for PIP4K in regulating growth in metazoans. We also found that overexpression of dPIP4K results in increased larval body weight. Thus, not only is dPIP4K required for normal larval development; the activity of this enzyme is also able to regulate weight gain and developmental rate in Drosophila.
The larval growth defect in dPIP4K 29 was not due to an inability to feed (Fig. S3A) and transcripts for the major DILPs (DILP2 and DILP5) that are known to regulate larval growth in response to nutrients (28) were not altered (Fig. S3B) , suggesting that defective DILP production is unlikely to underlie the growth defects of dPIP4K 29 . In this study, we found that dPIP4K is a regulator of cell size. The cell size reduction in dPIP4K 29 was accompanied by lowered levels of pS6K and could be rescued by overexpression of dS6K (Fig. 4) . S6K has a well-established and evolutionarily conserved role in determining cell size (22) . Our findings define dPIP4K acting via S6K as an important regulator of cell size during metazoan development.
In addition to reduced levels of pS6K, a signaling output of TORC1, dPIP4K 29 larvae showed enhanced sensitivity to growth on rapamycin (Fig. 5A) , supporting the conclusion that TORC1 activity is down-regulated in dPIP4K 29 larvae. We also found that phosphorylation of AKT at Ser505, a signaling output of the TORC2 complex, was substantially reduced in dPIP4K 29 . Thus, lack of dPIP4K results in a reduction in the signaling output of both TORC1 and TORC2 complexes in larvae. An economical interpretation of these observations is that the function of conserved components of both complexes might be down-regulated in dPIP4K 29 larvae. These could include (i) changes in the conserved protein components or the subcellular localization of both TOR complexes. (ii) An alternative possibility is that signaling inputs needed to activate the TORC complexes are impaired in the absence of dPIP4K. Our observation that overexpression of Rheb, a known direct activator of the TORC1 complex, can rescue the growth defect in dPIP4K 29 has two implications. First, it suggests that the intrinsic activity of the TORC1 complex in dPIP4K 29 cells is normal to the extent that it can be stimulated by Rheb. Second, that the underlying reason for the reduced growth in dPIP4K 29 cells is most likely a lack of signaling input to stimulate TORC1 activity. Our observation of increase in larval body mass, cell size, rate of larval development, and enhanced TOR-dependent phosphorylation of AKT and S6K seen with dPIP4K overexpression (in a kinase-dependent manner) further emphasize the fact that dPIP4K activity can regulate the activity of both TORC1 and TORC2. This observation provides compelling evidence of a role for the kinase activity of dPIP4K in regulating TOR signaling at or above the level of Rheb in Drosophila larval cells. In summary, our findings suggest that dPIP4K could be an additional regulator of nutritional or metabolic cues critical for regulating cell growth during Drosophila larval development via TORC activity.
Since the description of its distinctive enzymatic activity in vitro (8, 9) , the biochemical activity relevant to the function of PIP4K enzymes in vivo has been unclear. In this study, we found that flies lacking the only PIP4K gene in the Drosophila genome show increased levels of PI5P. This elevation of PI5P levels was dependent on the kinase activity of dPIP4K (Fig. 2E) , implying that the kinase activity of dPIP4K regulates PI5P levels in vivo. Although in vitro dPIP4K shows minimal activity to PI4P as a substrate, we found no changes in the levels of PI4P, suggesting that PIP4K activity is unlikely to be involved in the regulation of PI4P levels in vivo. Finally, the observation that PI(4,5)P 2 levels were not reduced in dPIP4K 29 suggests that this enzyme is not required to maintain global levels of PI(4,5)P 2 . Collectively our biochemical analysis of dPIP4K 29 strongly suggests that in vivo, the lipid kinase activity of dPIP4K is required to regulate PI5P levels ( Fig. 2 D and E) . Biochemical fractionation (Fig. S4) suggest that endogenous dPIP4K is present both at the plasma membrane and also to some extent at some internal endomembranes. Thus, the elevated levels of PI5P seen in dPIP4K 29 may occur at either of these subcellular locations. This is consistent with the previously reported enrichment of PI5P at the plasma membrane but also in intracellular membrane such as the Golgi (29) .
Although no in vivo targets of PI5P have been clearly demonstrated, a number of proteins that carry a plant homeodomain domain have been reported to bind PI5P in vivo (30) . In addition, in mammalian systems, it has been proposed that PI5P may regulate key molecules in the signaling pathway that mediates insulin signaling, namely the PIP 3 phosphatases phosphatase and tension homolog and Src homology 2 domain containing inositol 5′ phosphatase (17) or AKT (31) . The relevance of these proteins in mediating phenotypes due to loss of dPIP4K function remains to be established. Whereas it is possible that phenotypes related to loss of dPIP4K function may be a consequence of elevated PI5P levels, changes in a quantitatively minor pool of PI (4,5)P 2 generated by PIP4K cannot be excluded. Further studies will be required to resolve these questions.
Materials and Methods
Fly Culture. Unless otherwise specified, flies (Drosophila melanogaster) were reared on standard medium containing agar, yeast, cornmeal, and dextrose, along with antibacterial and antifungal agents. Cultures were maintained at 23°C and 50% relative humidity. The wild-type strain was Oregon-R.
Developmental Analysis of Growth. Flies were allowed to lay eggs for ≤4 h on cut bottles containing standard fly medium. Embryos were aged from the midpoint of that period. Newly hatched larvae were transferred to cut vials (20-25 larvae per vial) containing standard fly medium and reared at 23°C until the required developmental stage. For each time point (4-h intervals during the day and 8-h interval at night) separate vials were set up and scored to count the number of larvae that had pupariated. For weight measurements, newly hatched larvae were transferred onto fresh medium and reared at 23°C until the required developmental stage. Samples containing 10 larvae (n = 100 for each genotype) were measured using a precision balance (Sartorius; R160P).
Rapamycin Feeding. To measure the effect of rapamycin on development timing, groups of 20 newly hatched larvae from 4-h collection were placed in vials containing standard fly medium with or without 2 μM rapamycin (Sigma) and cultured at 23°C until eclosion. Experiments were conducted in triplicate and the results were averaged.
Imaging and Analysis of Data. Complete experiments and appropriate control sets have been done by acquiring images on either an Olympus FV1000 laser scanning confocal microscope, using 20× objective (UPLAPO series, N.A. 0.7) or a Zeiss 510 LSM (with 405) Meta point-scanning confocal microscope, using a 20× (Plan Neofluar, N.A. 0.5) and processed using Fiji (ImageJ). The total volume of the gland and the number of nuclei measured using Volocity image analysis software were used to estimate the average cell size. A total of at least five salivary glands from a minimum of five animals were analyzed for each genotype. Statistical analysis of the data (two-tailed T test) was performed using Excel (Microsoft Office package).
Western Immunoblotting. Samples were separated using SDS/PAGE and electroblotted onto supported nitrocellulose membrane (Hybond-C Extra; GE Healthcare) using wet transfer assembly (Bio-Rad). Blots were incubated overnight at 4°C in appropriate dilutions of primary antibody. Immunoreactive protein was visualized after incubation in 1:10,000 dilution of appropriate secondary antibody coupled to horseradish peroxidase (Jackson Immuno Research Laboratories) for 1 h at room temperature. Blots were developed with ECL (GE Healthcare) and imaged using a LAS 4000 instrument (GE Healthcare).
